Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Gobom

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Nature Aging|August 23, 2025
Plasma tau biomarkers for biological staging of Alzheimer's diseaseLaia Montoliu-Gaya, Gemma Salvadó, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's diseaseMiriam Rabl, Willem L Hartog, Wiesje M van der Flier, et al.
Nature Aging|May 17, 2023
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologiesLaia Montoliu-Gaya, Andréa L Benedet, Cécile Tissot, et al.
Alzheimer'S Research & Therapy|May 29, 2020
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's diseaseElles Konijnenberg, Betty M Tijms, Johan Gobom, et al.
Proteomes|August 27, 2021
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative IndividualsBetty Marije Tijms, Johan Gobom, Charlotte Teunissen, et al.
Alzheimer'S Research & Therapy|December 20, 2025
Fluid biomarkers for neurodegenerative diseases: a comprehensive updateMartina Valletta, Nils Briel, Idil Yuksekel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2023
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathologyKimberly Wolzak, Lisa Vermunt, Marta Del Campo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndromeMathias Sauer, Bárbara Fernandes Gomes, Parasto Shahrouki, et al.
Acta Neuropathologica Communications|July 5, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosisRicheng Jiang, Una Smailovic, Hazal Haytural, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2024
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3Daniel J Panyard, Lianne M Reus, Muhammad Ali, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Nature Aging|August 23, 2025
Plasma tau biomarkers for biological staging of Alzheimer's diseaseLaia Montoliu-Gaya, Gemma Salvadó, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's diseaseMiriam Rabl, Willem L Hartog, Wiesje M van der Flier, et al.
Nature Aging|May 17, 2023
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologiesLaia Montoliu-Gaya, Andréa L Benedet, Cécile Tissot, et al.
Alzheimer'S Research & Therapy|May 29, 2020
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's diseaseElles Konijnenberg, Betty M Tijms, Johan Gobom, et al.
Proteomes|August 27, 2021
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative IndividualsBetty Marije Tijms, Johan Gobom, Charlotte Teunissen, et al.
Alzheimer'S Research & Therapy|December 20, 2025
Fluid biomarkers for neurodegenerative diseases: a comprehensive updateMartina Valletta, Nils Briel, Idil Yuksekel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2023
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathologyKimberly Wolzak, Lisa Vermunt, Marta Del Campo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndromeMathias Sauer, Bárbara Fernandes Gomes, Parasto Shahrouki, et al.
Acta Neuropathologica Communications|July 5, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosisRicheng Jiang, Una Smailovic, Hazal Haytural, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2024
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3Daniel J Panyard, Lianne M Reus, Muhammad Ali, et al.
Pageof 14